BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 17918153)

  • 1. Insulin-like growth factor-I regulates the liver microenvironment in obese mice and promotes liver metastasis.
    Wu Y; Brodt P; Sun H; Mejia W; Novosyadlyy R; Nunez N; Chen X; Mendoza A; Hong SH; Khanna C; Yakar S
    Cancer Res; 2010 Jan; 70(1):57-67. PubMed ID: 20048072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of neutrophil polarization in colon carcinoma liver metastases of mice with an inducible, liver-specific IGF-I deficiency.
    Rayes RF; Milette S; Fernandez MC; Ham B; Wang N; Bourdeau F; Perrino S; Yakar S; Brodt P
    Oncotarget; 2018 Mar; 9(21):15691-15704. PubMed ID: 29644002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GH-dependent growth of experimentally induced carcinomas in vivo.
    Marker PC; Unterberger CJ; Swanson SM
    Endocr Relat Cancer; 2023 May; 30(5):. PubMed ID: 36826838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-Glucosidase Inhibitor Voglibose Suppresses Azoxymethane-Induced Colonic Preneoplastic Lesions in Diabetic and Obese Mice.
    Kato J; Shirakami Y; Mizutani T; Kubota M; Sakai H; Ibuka T; Shimizu M
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient rats.
    Carroll RE; Goodlad RA; Poole AJ; Tyner AL; Robey RB; Swanson SM; Unterman TG
    Growth Horm IGF Res; 2009 Oct; 19(5):447-56. PubMed ID: 19406679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Components of metabolic syndrome and metachronous colorectal neoplasia.
    Ashbeck EL; Jacobs ET; Martínez ME; Gerner EW; Lance P; Thompson PA
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1134-43. PubMed ID: 19318435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Number of aberrant crypt foci associated with adiposity and IGF1 bioavailability.
    Swede H; Rohan TE; Yu H; Anderson JC; Stevens RG; Brokaw J; Levine J; Brenner BM; Malchoff CD; Duffy VB; Pleau DC; Rosenberg DW
    Cancer Causes Control; 2009 Jul; 20(5):653-61. PubMed ID: 19067190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating IGF-1 and its role in cancer: lessons from the IGF-1 gene deletion (LID) mouse.
    Yakar S; Pennisi P; Zhao H; Zhang Y; LeRoith D
    Novartis Found Symp; 2004; 262():3-9; discussion 9-18, 265-8. PubMed ID: 15562820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I.
    Sjögren K; Jansson JO; Isaksson OG; Ohlsson C
    Minerva Endocrinol; 2002 Dec; 27(4):299-311. PubMed ID: 12511852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon carcinogenesis in liver-specific IGF-I-deficient (LID) mice.
    Ealey KN; Xuan W; Lu S; Archer MC
    Int J Cancer; 2008 Jan; 122(2):472-6. PubMed ID: 17918153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-dependent onset of liver-specific IGF-I gene deficiency and its persistence in old age: implications for postnatal growth and insulin resistance in LID mice.
    Tang Z; Yu R; Lu Y; Parlow AF; Liu JL
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E288-95. PubMed ID: 15769793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.
    Wu Y; Yakar S; Zhao L; Hennighausen L; LeRoith D
    Cancer Res; 2002 Feb; 62(4):1030-5. PubMed ID: 11861378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic reduction of circulating insulin-like growth factor-1 inhibits azoxymethane-induced colon tumorigenesis in mice.
    Olivo-Marston SE; Hursting SD; Lavigne J; Perkins SN; Maarouf RS; Yakar S; Harris CC
    Mol Carcinog; 2009 Dec; 48(12):1071-6. PubMed ID: 19760669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors.
    Wu Y; Cui K; Miyoshi K; Hennighausen L; Green JE; Setser J; LeRoith D; Yakar S
    Cancer Res; 2003 Aug; 63(15):4384-8. PubMed ID: 12907608
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.